分子診斷的全球市場，到2029年的預測

分子診斷激發成長機會並推動創新的個人化醫療

由於多種因素，包括 COVID-19 大流行導致的需求增加、癌症病例數量增加以及技術力的快速發展，全球分子診斷市場預計將顯著成長。

聚合酵素鏈鎖反應（PCR）、數位 PCR 和次世代定序（NGS）等技術的進步提高了分子檢測的準確性和生產力，並實現了個人化治療。

預測分析按區域和應用程式進行細分。後者包括傳染病檢查、腫瘤學檢測、基因檢測和其他分子診斷。由於方法上的限制，Frost & Sullivan對該行業的預測採用定性方法進行成長機會分析。

癌症發生率的增加加速了對先進分子診斷工具的需求，而慢性病的增加、政府醫療保健的現代化以及對個人化醫療的需求不斷增加將推動分子診斷行業的顯著成長。集中的醫療監管和強大的研發投資將促進這一擴張。

目錄

成長環境

• 成長環境

策略要務

• 為什麼成長越來越困難？
• The Strategic Imperative 8（TM）
• 關鍵策略要務對全球分子診斷產業的影響
• 全球分子診斷公司的策略要務
• 成長機會推動Growth Pipeline Engine（TM）

成長機會分析

• 分析範圍
• 全球分子診斷的應用細分

概述

• 成長指標
• 生長促進因子
• 成長抑制因素
• 預測假設

收益預測

• 收益預測
• 全球分子診斷收益預測分析
• 收益預測，依地區
• 全球分子診斷收益預測分析，依地區
• 全球分子診斷市場分析，依技術
• 收益預測，依用途
• 全球分子診斷收益預測，依用途

競爭格局

• 競爭環境
• 全球分子診斷公司收益佔有率
• 全球分子診斷收益佔有率分析
• 主要競爭對手
• 分子診斷產品的競爭性繪圖

併購

• 全球分子診斷市場：值得關注的併購

特色企業

• 分子診斷領域的知名公司

成長機會宇宙

• 成長機會概覽
• 成長機會1：POC測試的進步
• 成長機會2：發現遺傳標記和療法的個人化癌症治療
• 成長機會3：利用下一代分子診斷技術整合生物標記開發與伴同性診斷
• 成長機會4：加強居家健康監測

下一步

Molecular Diagnostics Unleash Growth Opportunities, Steering Innovation Personalized Medicine

The global molecular diagnostic market will experience significant growth due to a broad range of factors, such as increased demand from the COVID-19 pandemic, an increasing number of cancer cases, and the swift evolution of technological capabilities.

Technological advancements, such as polymerase chain reaction (PCR), digital PCR, and next-generation sequencing (NGS), have improved molecular testing accuracy and productivity, enabling personalized treatment.

The forecast analysis is segmented by region and by application. The latter includes infectious disease testing, oncology testing, genetic testing, and other molecular diagnostics. Frost & Sullivan's forecasts for this industry use a qualitative approach for the growth opportunity analyses due to methodological constraints.

The growing prevalence of cancer has accelerated the need for advanced molecular diagnostic tools, while the rise in chronic diseases, the modernization of government healthcare, and the growing demand for personalized medicine will contribute to the significant growth anticipated in the molecular diagnostics industry. Focused healthcare regulations and substantial R&D investments facilitate this expansion.

Table of Contents

Growth Environment

• Growth Environment

Strategic Imperatives

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Global Molecular Diagnostics Industry
• Strategic Imperatives for Global Molecular Diagnostics Companies
• Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

• Scope of Analysis
• Global Molecular Diagnostics Application Segmentation

Overview

• Growth Metrics
• Growth Drivers
• Growth Restraints
• Forecast Assumptions

Revenue Forecast

• Revenue Forecast
• Global Molecular Diagnostics Revenue Forecast Analysis
• Revenue Forecast by Region
• Global Molecular Diagnostics Revenue Forecast Analysis by Region
• Global Molecular Diagnostics Market Analysis by Technology
• Revenue Forecast by Application
• Global Molecular Diagnostics Revenue Forecast by Application

Competitive Landscape

• Competitive Environment
• Global Molecular Diagnostics Revenue Share by Player
• Global Molecular Diagnostics Revenue Share Analysis
• Key Competitors
• Competitive Mapping by Molecular Diagnostics Offering

Mergers and Acquisitions

• Global Molecular Diagnostics Market: Notable M&A

Companies to Watch

• Molecular Diagnostics Companies to Watch

Growth Opportunity Universe

• Growth Opportunity Summary
• Growth Opportunity 1: Advancements in Point-of-care Testing
• Growth Opportunity 2: Personalized Cancer Treatment Unveiling Genetic Markers and Therapies
• Growth Opportunity 3: Leveraging Next-gen Molecular Diagnostics Technologies for Biomarker Development and Companion Diagnostics Integration
• Growth Opportunity 4: Enhancing Home Health Monitoring

Next Steps

• Your Next Steps
• Why Frost, Why Now?
• List of Exhibits
• Legal Disclaimer